These findings imply that cystatin C may be a useful marker for all-cause, cardiovascular and cancer mortality risk estimation, which does not differ by subgroups of sex, age, BMI, current smoking status, current alcohol consumption, and regular exercise. This evidence concerns the gene CST3 and cancer.